Bal Pharma [BALPHARMA] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Bal Pharma

NSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bal Pharma wins in 6 metrics, Sun Pharmaceutical wins in 14 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBal PharmaSun PharmaceuticalBetter
P/E Ratio (TTM)18.8236.74Bal Pharma
Price-to-Book Ratio2.175.30Bal Pharma
Debt-to-Equity Ratio196.553.26Sun Pharmaceutical
PEG Ratio-1.00-1.89Sun Pharmaceutical
EV/EBITDA9.0723.33Bal Pharma
Profit Margin (TTM)2.43%19.29%Sun Pharmaceutical
Operating Margin (TTM)5.37%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)5.37%24.34%Sun Pharmaceutical
Return on Equity9.32%15.08%Sun Pharmaceutical
Return on Assets (TTM)2.15%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$15.28M$119.44BSun Pharmaceutical
Dividend Yield1.20%1.26%Sun Pharmaceutical
1-Year Return-36.30%-14.34%Sun Pharmaceutical
Price-to-Sales Ratio (TTM)0.467.11Bal Pharma
Enterprise Value$2.71B$3,578.34BSun Pharmaceutical
EV/Revenue Ratio0.926.65Bal Pharma
Gross Profit Margin (TTM)49.08%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$188$224Sun Pharmaceutical
Earnings per Share (Diluted)$4.51$43.39Sun Pharmaceutical
Beta (Stock Volatility)0.180.31Bal Pharma
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bal Pharma vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Bal Pharma
Sun Pharmaceutical
Bal Pharma Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bal Pharma0.93%-1.89%-5.49%-17.78%-6.87%-33.49%
Sun Pharmaceutical-0.31%0.56%4.66%-1.86%-3.66%-13.43%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bal Pharma-36.30%-11.41%27.35%11.04%155.48%43.89%
Sun Pharmaceutical-14.34%71.30%219.01%80.56%692.58%2,617.04%

News Based Sentiment: Bal Pharma vs Sun Pharmaceutical

Bal Pharma

News based Sentiment: NEGATIVE

The significant declines in revenue, net profit, and the longer-term share price performance paint a concerning picture for Bal Pharma. While there was a minor daily price increase, the overall narrative is one of financial challenges and investor skepticism, making this a noteworthy month for investors.

View Bal Pharma News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Bal Pharma vs Sun Pharmaceutical

MetricBALPHARMASUNPHARMA
Market Information
Market Cap i₹1.37B₹3.92T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i39,1032,839,112
90 Day Avg. Volume i28,1922,655,594
Last Close₹84.45₹1,631.20
52 Week Range₹78.06 - ₹140.95₹1,548.00 - ₹1,952.25
% from 52W High-40.09%-16.45%
All-Time High₹167.90 (Jan 11, 2016)₹1,960.35 (Sep 30, 2024)
% from All-Time High-49.70%-16.79%
Growth Metrics
Quarterly Revenue Growth-0.11%0.10%
Quarterly Earnings Growth-0.23%-0.20%
Financial Health
Profit Margin (TTM) i0.02%0.19%
Operating Margin (TTM) i0.05%0.24%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i196.553.26
Cash & Liquidity
Book Value per Share (MRQ)₹39.09₹300.99
Cash per Share (MRQ)₹6.82₹108.88
Operating Cash Flow (TTM) i₹74.55M₹110.84B
Levered Free Cash Flow (TTM) i₹72.15M₹109.29B
Dividends
Last 12-Month Dividend Yield i1.20%1.26%
Last 12-Month Dividend i₹1.20₹21.00

Valuation & Enterprise Metrics Analysis: Bal Pharma vs Sun Pharmaceutical

MetricBALPHARMASUNPHARMA
Price Ratios
P/E Ratio (TTM) i18.8236.74
Forward P/E iN/A48.79
PEG Ratio i-1.00-1.89
Price to Sales (TTM) i0.467.11
Price to Book (MRQ) i2.175.30
Market Capitalization
Market Capitalization i₹1.37B₹3.92T
Enterprise Value i₹2.71B₹3.58T
Enterprise Value Metrics
Enterprise to Revenue i0.926.65
Enterprise to EBITDA i9.0723.33
Risk & Other Metrics
Beta i0.180.31
Book Value per Share (MRQ) i₹39.09₹300.99

Financial Statements Comparison: Bal Pharma vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BALPHARMASUNPHARMA
Revenue/Sales i₹658.71M₹137.86B
Cost of Goods Sold i₹335.43M₹28.15B
Gross Profit i₹323.28M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹35.40M₹33.72B
EBITDA i₹67.82M₹47.66B
Pre-Tax Income i₹2.09M₹31.73B
Income Tax i₹0₹8.70B
Net Income (Profit) i₹2.09M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BALPHARMASUNPHARMA
Cash & Equivalents i₹17.52M₹102.69B
Total Current Assets i₹2.35B₹526.24B
Total Current Liabilities i₹2.20B₹181.94B
Long-Term Debt i₹326.90M₹3.58B
Total Shareholders Equity i₹774.04M₹724.86B
Retained Earnings i₹273.10M₹578.62B
Property, Plant & Equipment i₹709.91M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BALPHARMASUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBALPHARMASUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i39,1032,839,112
Average Daily Volume (90 Day) i28,1922,655,594
Shares Outstanding i15.92M2.40B
Float Shares i5.30M1.04B
% Held by Insiders i0.65%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Bal Pharma vs Sun Pharmaceutical

MetricBALPHARMASUNPHARMA
Last 12-Month Dividend i₹1.20₹21.00
Last 12-Month Dividend Yield i1.20%1.26%
3-Year Avg Annual Dividend i₹1.07₹14.67
3-Year Avg Dividend Yield i1.01%0.46%
3-Year Total Dividends i₹3.20₹44.00
Ex-Dividend DateSep 17, 2024Jul 07, 2025